Development and validation of a novel circulating fibroblast activation protein - based predictive model to improve fibrosis risk stratification in metabolic liver disease population
View ORCID ProfileZiqi V Wang, View ORCID ProfileBadwi B Boumelhem, Torsten Pennell, View ORCID ProfileWilliam W Bachovchin, Jack Hung-Sen Lai, Sarah E Poplawski, View ORCID ProfilePieter Van Der Veken, Kate Brewer, View ORCID ProfileGeraldine Ooi, View ORCID ProfileJacob George, View ORCID ProfileMohamed Eslam, View ORCID ProfileLeon A Adams, View ORCID ProfileHui Emma Zhang, View ORCID ProfileGeoffrey W McCaughan, View ORCID ProfileAvik Majumdar, View ORCID ProfileMark D Gorrell
doi: https://doi.org/10.1101/2024.07.19.24310730
Ziqi V Wang
1Liver Enzymes in Metabolism and Inflammation, Centenary Institute, and The Faculty of Medicine and Health, The University of Sydney, NSW, Australia
Badwi B Boumelhem
1Liver Enzymes in Metabolism and Inflammation, Centenary Institute, and The Faculty of Medicine and Health, The University of Sydney, NSW, Australia
Torsten Pennell
1Liver Enzymes in Metabolism and Inflammation, Centenary Institute, and The Faculty of Medicine and Health, The University of Sydney, NSW, Australia
William W Bachovchin
2Department of Developmental, Molecular and Chemical Biology, Graduate School of Biomedical Sciences, Tufts University, Boston, Massachusetts, 02111, United States
Jack Hung-Sen Lai
2Department of Developmental, Molecular and Chemical Biology, Graduate School of Biomedical Sciences, Tufts University, Boston, Massachusetts, 02111, United States
Sarah E Poplawski
2Department of Developmental, Molecular and Chemical Biology, Graduate School of Biomedical Sciences, Tufts University, Boston, Massachusetts, 02111, United States
Pieter Van Der Veken
3Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, 2610 Wilrijk, Belgium; Department of Surgery
Kate Brewer
1Liver Enzymes in Metabolism and Inflammation, Centenary Institute, and The Faculty of Medicine and Health, The University of Sydney, NSW, Australia
Geraldine Ooi
4Monash University, Victoria, Australia
Jacob George
5Storr Liver Centre, The Westmead Institute for Medical Research, Westmead Hospital and The University of Sydney, Westmead, NSW, 2145
Mohamed Eslam
5Storr Liver Centre, The Westmead Institute for Medical Research, Westmead Hospital and The University of Sydney, Westmead, NSW, 2145
Leon A Adams
6Medical School, Faculty of Medicine and Health Sciences, The University of Western Australia, Australia
Hui Emma Zhang
1Liver Enzymes in Metabolism and Inflammation, Centenary Institute, and The Faculty of Medicine and Health, The University of Sydney, NSW, Australia
Geoffrey W McCaughan
1Liver Enzymes in Metabolism and Inflammation, Centenary Institute, and The Faculty of Medicine and Health, The University of Sydney, NSW, Australia
7AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown, NSW, 2050
Avik Majumdar
1Liver Enzymes in Metabolism and Inflammation, Centenary Institute, and The Faculty of Medicine and Health, The University of Sydney, NSW, Australia
7AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown, NSW, 2050
8Department of Gastroenterology, Austin Hospital, Melbourne, Australia
Mark D Gorrell
1Liver Enzymes in Metabolism and Inflammation, Centenary Institute, and The Faculty of Medicine and Health, The University of Sydney, NSW, Australia
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted July 22, 2024.
Development and validation of a novel circulating fibroblast activation protein - based predictive model to improve fibrosis risk stratification in metabolic liver disease population
Ziqi V Wang, Badwi B Boumelhem, Torsten Pennell, William W Bachovchin, Jack Hung-Sen Lai, Sarah E Poplawski, Pieter Van Der Veken, Kate Brewer, Geraldine Ooi, Jacob George, Mohamed Eslam, Leon A Adams, Hui Emma Zhang, Geoffrey W McCaughan, Avik Majumdar, Mark D Gorrell
medRxiv 2024.07.19.24310730; doi: https://doi.org/10.1101/2024.07.19.24310730
Development and validation of a novel circulating fibroblast activation protein - based predictive model to improve fibrosis risk stratification in metabolic liver disease population
Ziqi V Wang, Badwi B Boumelhem, Torsten Pennell, William W Bachovchin, Jack Hung-Sen Lai, Sarah E Poplawski, Pieter Van Der Veken, Kate Brewer, Geraldine Ooi, Jacob George, Mohamed Eslam, Leon A Adams, Hui Emma Zhang, Geoffrey W McCaughan, Avik Majumdar, Mark D Gorrell
medRxiv 2024.07.19.24310730; doi: https://doi.org/10.1101/2024.07.19.24310730
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2952)
- Dermatology (250)
- Emergency Medicine (440)
- Epidemiology (12757)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4593)
- Geriatric Medicine (420)
- Health Economics (729)
- Health Informatics (2923)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (469)
- Neurology (4366)
- Nursing (237)
- Nutrition (640)
- Oncology (2274)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (498)
- Public and Global Health (6949)
- Radiology and Imaging (1531)
- Respiratory Medicine (915)
- Rheumatology (439)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)